# BioRaptor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioraptor

- Industry: Biotechnology
- Headquarters: Israel
- Website: www.bioraptor.ai
- Total disclosed funding: $3M
- Latest round: Seed (Oct 31, 2022)
- Investors on record: 3

## About

Based in Binyamina, Israel, and founded in 2021 by CEO Ori Zakin, and CTO Yaron David, BioRaptor is developing an operating system for biology research and manufacturing companies by leveraging artificial intelligence (AI) technology to present a clear understanding of data and creating deep, actionable insights, integrated within existing workflows. In October 2022, BioRaptor raised USD 3 million in seed funding co-led by CPT Capital, and lool ventures, with participation from HackVentures Ltd.

The company provides an AI-powered insight platform that collects, harmonizes, and analyses multimodal data to generate actionable scientist-friendly insights. The platform allows scientists as well as biotech companies to discover, develop and scale processes related to alternative protein food and new biopharmaceuticals to get much-needed food and pharma products.

BioRaptor plans to use its proceeds from October 2022 funding to innovate the biotech industry by putting the power of AI-generated insights into the hands of every scientist. The company also plans to ramp up development and onboard additional customers.

## Funding rounds

- Seed, Oct 31, 2022, $3M — lool ventures, CPT Capital, HackVentures Ltd.

## Investors

- lool ventures (https://capitalatlas.ai/funds/lool-ventures) — Seed
- CPT Capital — Seed
- HackVentures Ltd. — Seed
